Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Saved in:
Bibliographic Details
Title: Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
Authors: Wesa KM; Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY, 10021, USA., Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2015 Feb; Vol. 64 (2), pp. 237-47. Date of Electronic Publication: 2014 Oct 29.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0851
DOI:10.1007/s00262-014-1628-6